S&P 500 Snapshot: Index Retreats From Record High

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.Is this happening to you frequently? Please report it on our feedback forum.If you have

By News Room

Buy Any Of January’s 6 Ideal ‘Safer’ Dividend Power Dogs

By News Room

This article was written byFollowFredrik Arnold is a former quality service analyst. He is now reporting investment ideas with a

First Majestic Silver (AG): Scale, Discipline, And Beta To Silver Make It A Strong Buy

By News Room

This article was written byFollowI work on the buy-side in Fixed Income. In my spare time, I'm out here Seeking

Weekly Market Pulse: It Ain’t What You Don’t Know

By News Room

Joe has worked in the financial services industry since 1992 in various capacities, including Operations Manager, Compliance Manager, Registered Representative

2026 Outlook: Why 3.1 Is A Game-Changer For Nebius Stock (NASDAQ:NBIS)

By News Room

This article was written byFollowI hold a Master’s degree in Cell Biology and began my career working for several years

John Hancock Diversified Macro Fund Q3 2025 Commentary (Mutual Fund:JDJAX)

By News Room

A company of Manulife Investment Management, John Hancock Investment Management serves investors through a unique multimanager approach, complementing our extensive

SmartStop Self Storage: A REIT To Hold, Awaiting Stronger Market Revival (NYSE:SMA)

By News Room

This article was written byFollowAlbert Anthony is the pen name of a Croatian-American business author who is a contributing analyst

Tenaz Energy: 3x Production Growth Ahead In The TTF Gas Market, Yet Deeply Undervalued

By News Room

This article was written byFollowLaurentian Research is a resource industry veteran with a Ph.D. in geoscience and decades of investment

CLM: Understanding Its Distributions, NAV Erosion, And Investor Outcomes (NYSE:CLM)

By News Room

This article was written byFollowI have a B.Tech degree in Mechanical Engineering from a top school in India. For nearly

Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL)

By News Room

This article was written byFollowhttps://biotechpharmainvestor.substack.comBackground: Physician involved in clinical research. Investment style: Clinical-stage biotech stocks, long only, both long-term ideas

How My Seeking Alpha Stock Portfolio Crushed S&P 500

By News Room

This article was written byFollow"Fundamental Options" would be the title of my investing style, because I combine fundamental analysis with

Broadcom: My Best AI Investment Idea For 2026 (NASDAQ:AVGO)

By News Room

This article was written byFollowI’m a retail investor based in Sydney with three years of experience focusing on achieving financial

Columbia Strategic Municipal Income Fund Q3 2025 Commentary (Mutual Fund:INTAX)

By News Room

Columbia Threadneedle Investments is a leading global asset management group that provides a broad range of actively managed investment strategies